Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.77 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.77 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.77 |
| ▸ | TTR | P02766 | 3/20 | 0.77 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.77 |
| ▸ | ABL1 | P00519 | 4/20 | 0.69 |
| ▸ | BCR | P11274 | 4/20 | 0.69 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pinosylvin Methyl Ether SCHEMBL9419826 | 1.00 | KDM4E (1.00) | KDM4EMEN1MAPTKMT2AUSP2 | |
| Pinosylvin Methyl Ether SCHEMBL29928865 | 1.00 | KDM4E (1.00) | KDM4EMEN1MAPTKMT2AUSP2 | |
| Pinosylvin Methyl Ether SCHEMBL1650247 | 1.00 | KDM4E (1.00) | KDM4EMEN1MAPTKMT2AUSP2 | |
| Pinosylvin Methyl Ether SCHEMBL30334927 | 1.00 | KDM4E (1.00) | KDM4EMEN1MAPTKMT2AUSP2 | |
| Pterostilbene SCHEMBL3476943 | 0.89 | NQO2 (0.86) | KDM4EMEN1MAPTKMT2AUSP2 | |
| Pterostilbene SCHEMBL3476941 | 0.89 | NQO2 (0.86) | KDM4EMEN1MAPTKMT2AUSP2 | |
| 3,5-O-Dimethylpinosylvin SCHEMBL918726 | 0.88 | KDM4E (0.79) | KDM4EMEN1MAPTKMT2AUSP2 | |
| 3,5-O-Dimethylpinosylvin SCHEMBL9419809 | 0.88 | KDM4E (0.79) | KDM4EMEN1MAPTKMT2AUSP2 | |
| 3,5-O-Dimethylpinosylvin SCHEMBL918727 | 0.88 | KDM4E (0.79) | KDM4EMEN1MAPTKMT2AUSP2 | |
| SCHEMBL23410069 | 0.87 | ABL1 (0.90) | KDM4EMEN1MAPTKMT2AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4436538-A1 | COSMETIC OR PHARMACEUTICAL PREPARATION FOR SKIN CARE AND IMPROVING SKIN CONDITION | Merryvital AG (CH) | 2024-10-02 | — | — | EP | claimed |
| CN-118401224-A | Cosmetic or cosmeceutical product for skin care and improving skin condition | 迈瑞维拓股份公司 | 2024-07-26 | — | — | CN | claimed |
| WO-2023094852-A1 | COSMETIC OR PHARMACEUTICAL PREPARATION FOR SKIN CARE AND IMPROVING SKIN CONDITION | MERRYVITAL AG (CH) | 2023-06-01 | — | — | WO | claimed |
| WO-2009118338-A2 | USE OF A POLYPHENOLIC TYPE COMPOUND FOR PREVENTING OR TREATING A POLYGLUTAMINE EXPANSION NEURODEGENERATIVE DISEASE | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2009-10-01 | — | — | WO | claimed |
| EP-2005941-A2 | Cellular rejuvenation compounds | Henkel AG & Co. KGaA (DE) | 2008-12-24 | — | — | EP | claimed |
| US-20080139650-A1 | Fungicidally Active Polymer Dispersions And Use Thereof | CELANESE EMULSIONS GMBH (DE) | 2008-06-12 | — | — | US | claimed |
| US-20070292545-A1 | ANTI-INFECTIVE AGENTS AND METHODS OF USE | WISYS TECHNOLOGY FOUNDATION | 2007-12-20 | — | — | US | claimed |
| JP-9241617-A | — | — | None | — | — | JP | disclosed |
| EP-4436538-A1 | COSMETIC OR PHARMACEUTICAL PREPARATION FOR SKIN CARE AND IMPROVING SKIN CONDITION | Merryvital AG (CH) | 2024-10-02 | — | — | EP | disclosed |
| CN-118401224-A | Cosmetic or cosmeceutical product for skin care and improving skin condition | 迈瑞维拓股份公司 | 2024-07-26 | — | — | CN | disclosed |
| WO-2023094852-A1 | COSMETIC OR PHARMACEUTICAL PREPARATION FOR SKIN CARE AND IMPROVING SKIN CONDITION | MERRYVITAL AG (CH) | 2023-06-01 | — | — | WO | disclosed |
| CN-113244203-A | 9, 10-dihydrophenanthrenes and their use for the treatment of liver injury | 中国科学院上海药物研究所 | 2021-08-13 | — | — | CN | disclosed |
| EP-2238967-B1 | Skin treatment fighting skin aging II | HENKEL AG & CO KGAA (DE) | 2018-05-02 | — | — | EP | disclosed |
| US-20020055541-A1 | Compositions containing hypotriglyceridemically active stilbenoids | SHAMAN PHARMACEUTICALS, INC. | 2002-05-09 | — | — | US | disclosed |
| WO-2002013811-A2 | COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS | INSMED INCORPORATED (US) | 2002-02-21 | — | — | WO | disclosed |
| WO-2002013809-A2 | COMPOSITIONS CONTAINING HYPOTRIGLYCERIDEMICALLY ACTIVE STILBENOIDS | INSMED INCORPORATED (US) | 2002-02-21 | — | — | WO | disclosed |
| WO-2002014252-A2 | COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS | INSMED INCORPORATED (US) | 2002-02-21 | — | — | WO | disclosed |
| WO-2002013806-A2 | COMPOSITIONS CONTAINING HYPOTRIGLYCERIDEMICALLY ACTIVE STILBENOIDS | INSMED INCORPORATED (US) | 2002-02-21 | — | — | WO | disclosed |
| JP-H09241617-A | ULTRAVIOLET ABSORBENT | YUSHIRO CHEM IND CO LTD | 1997-09-16 | — | — | JP | disclosed |
| US-5314693-A | Hydroxystilbene compounds | KIORITZ CORPORATION (JP) | 1994-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139650-A1 | Fungicidally Active Polymer Dispersions And Use Thereof | CBR3, CBR1, CYP3A4 | KDM4E 1199/4885MEN1 2062/4885MAPT 3690/4885 |
| US-20020055541-A1 | Compositions containing hypotriglyceridemically active stilbenoids | CPT1B, CPT1A, LIPC | KDM4E 3393/4885MEN1 2300/4885MAPT 1859/4885 |
| US-20070292545-A1 | ANTI-INFECTIVE AGENTS AND METHODS OF USE | H1-3, H1-0, H1-2 | KDM4E 1612/4885MEN1 2664/4885MAPT 4879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.